Related Experiment Video
Updated: Jun 29, 2025

06:46
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
261
Prognosis of primary breast salivary gland-type carcinoma: a propensity score-matching analysis with invasive
1Advanced Medical and Dental Institute, Universiti Sains Malaysia, Penang, Malaysia. eschng@usm.my.
Breast Cancer (Tokyo, Japan)
|March 28, 2024
Summary
Primary breast salivary gland-type carcinoma (SGTCA) has similar outcomes to invasive carcinoma of no special type (NST) when adjusted for prognostic factors. Tumor grade and AJCC stage are crucial for managing SGTCA.
Area of Science:
- Oncology
- Pathology
- Cancer Research
Background:
- Primary breast salivary gland-type carcinoma (SGTCA) is rare, with limited data on its clinical features and prognosis.
- Management guidelines for SGTCA lack robust evidence.
- Comparison with common invasive breast carcinoma of no special type (NST) is needed.
Purpose of the Study:
- To assess clinicopathological features and prognosis of primary breast SGTCA.
- To compare the prognosis of SGTCA with invasive breast carcinoma NST.
- To identify significant prognostic factors for SGTCA.
Main Methods:
- Utilized the Surveillance, Epidemiology, and End Results (SEER) database.
- Extracted data on primary breast SGTCA cases diagnosed over the past decade.
- Employed propensity score-matching to compare SGTCA prognosis with invasive carcinoma NST.
Main Results:
- Included 488 SGTCA cases and 375,660 invasive carcinoma NST cases (ratio 1:770).
- Adenoid cystic carcinoma (81%) and secretory carcinoma (13%) were the main SGTCA subtypes.
- Tumor grade 3, higher AJCC stage, acinic cell carcinoma type, and HER2 overexpression were associated with worse survival in univariate analysis. After adjustment, tumor grade and AJCC stage remained significant. SGTCA survival advantage diminished post-adjustment.
Conclusions:
- Management of SGTCA should emphasize tumor grade, AJCC stage, acinic cell carcinoma type, and HER2 overexpression.
- Conventional prognostic factors are important for SGTCA.
- SGTCA prognosis is similar to invasive carcinoma NST after adjusting for confounding variables.
More Related Videos
Related Concept Videos
Cancer Survival Analysis
345
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
345
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K

